182 related articles for article (PubMed ID: 37670287)
1. Cardiovascular disease and all-cause mortality associated with individual and combined cardiometabolic risk factors.
Cao X; Zhang L; Wang X; Chen Z; Zheng C; Chen L; Zhou H; Cai J; Hu Z; Tian Y; Gu R; Huang Y; Wang Z
BMC Public Health; 2023 Sep; 23(1):1725. PubMed ID: 37670287
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease.
Abdullah SM; Defina LF; Leonard D; Barlow CE; Radford NB; Willis BL; Rohatgi A; McGuire DK; de Lemos JA; Grundy SM; Berry JD; Khera A
Circulation; 2018 Nov; 138(21):2315-2325. PubMed ID: 30571575
[TBL] [Abstract][Full Text] [Related]
3. Individual and Combined Cardiometabolic Morbidities and the Subsequent Risk of Cardiovascular Events in Chinese Adults.
Wang J; Wang Z; Guo F; Zhang Y; Ji H; Chen G; Wan Q; Yan L; Wang G; Qin Y; Luo Z; Tang X; Huo Y; Hu R; Ye Z; Shi L; Gao Z; Su Q; Mu Y; Zhao J; Chen L; Zeng T; Yu X; Li Q; Shen F; Chen L; Zhang Y; Wang Y; Deng H; Liu C; Wu S; Yang T; Li M; Xu Y; Xu M; Zhao Z; Wang T; Lu J; Bi Y; Wang W; Ning G; Zhao Y; Qin G
J Clin Endocrinol Metab; 2022 Jan; 107(1):e84-e94. PubMed ID: 34427675
[TBL] [Abstract][Full Text] [Related]
4. Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis.
Wekker V; van Dammen L; Koning A; Heida KY; Painter RC; Limpens J; Laven JSE; Roeters van Lennep JE; Roseboom TJ; Hoek A
Hum Reprod Update; 2020 Nov; 26(6):942-960. PubMed ID: 32995872
[TBL] [Abstract][Full Text] [Related]
5. Statins for the primary prevention of cardiovascular disease.
Taylor F; Huffman MD; Macedo AF; Moore TH; Burke M; Davey Smith G; Ward K; Ebrahim S
Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD004816. PubMed ID: 23440795
[TBL] [Abstract][Full Text] [Related]
6. The predictive study of the relation between elevated low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and mortality in peritoneal dialysis.
Lin T; Xia X; Yu J; Qiu Y; Yi C; Lin J; Mao H; Yang X; Huang F
Lipids Health Dis; 2020 Mar; 19(1):51. PubMed ID: 32199459
[TBL] [Abstract][Full Text] [Related]
7. Nordic dietary patterns and cardiometabolic outcomes: a systematic review and meta-analysis of prospective cohort studies and randomised controlled trials.
Massara P; Zurbau A; Glenn AJ; Chiavaroli L; Khan TA; Viguiliouk E; Mejia SB; Comelli EM; Chen V; Schwab U; Risérus U; Uusitupa M; Aas AM; Hermansen K; Thorsdottir I; Rahelić D; Kahleová H; Salas-Salvadó J; Kendall CWC; Sievenpiper JL
Diabetologia; 2022 Dec; 65(12):2011-2031. PubMed ID: 36008559
[TBL] [Abstract][Full Text] [Related]
8. Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults.
Palmer MJ; Machiyama K; Woodd S; Gubijev A; Barnard S; Russell S; Perel P; Free C
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD012675. PubMed ID: 33769555
[TBL] [Abstract][Full Text] [Related]
9. Multiple risk factor interventions for primary prevention of cardiovascular disease in low- and middle-income countries.
Uthman OA; Hartley L; Rees K; Taylor F; Ebrahim S; Clarke A
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD011163. PubMed ID: 26272648
[TBL] [Abstract][Full Text] [Related]
10. Ezetimibe for the prevention of cardiovascular disease and all-cause mortality events.
Zhan S; Tang M; Liu F; Xia P; Shu M; Wu X
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012502. PubMed ID: 30480766
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease.
Welsh C; Celis-Morales CA; Brown R; Mackay DF; Lewsey J; Mark PB; Gray SR; Ferguson LD; Anderson JJ; Lyall DM; Cleland JG; Jhund PS; Gill JMR; Pell JP; Sattar N; Welsh P
Circulation; 2019 Aug; 140(7):542-552. PubMed ID: 31216866
[TBL] [Abstract][Full Text] [Related]
12. Cardiometabolic Risk Factors and Incident Cardiovascular Disease Events in Women vs Men With Type 1 Diabetes.
Braffett BH; Bebu I; El Ghormli L; Cowie CC; Sivitz WI; Pop-Busui R; Larkin ME; Gubitosi-Klug RA; Nathan DM; Lachin JM; Dagogo-Jack S;
JAMA Netw Open; 2022 Sep; 5(9):e2230710. PubMed ID: 36074461
[TBL] [Abstract][Full Text] [Related]
13. Explaining the increase of incidence and mortality from cardiovascular disease in Indonesia: A global burden of disease study analysis (2000-2019).
Harmadha WSP; Muharram FR; Gaspar RS; Azimuth Z; Sulistya HA; Firmansyah F; Multazam CECZ; Harits M; Putra RM
PLoS One; 2023; 18(12):e0294128. PubMed ID: 38100501
[TBL] [Abstract][Full Text] [Related]
14. Association of Low-Density Lipoprotein Cholesterol Levels with More than 20-Year Risk of Cardiovascular and All-Cause Mortality in the General Population.
Rong S; Li B; Chen L; Sun Y; Du Y; Liu B; Robinson JG; Bao W
J Am Heart Assoc; 2022 Aug; 11(15):e023690. PubMed ID: 35904192
[TBL] [Abstract][Full Text] [Related]
15. Association Between Residential Greenness, Cardiometabolic Disorders, and Cardiovascular Disease Among Adults in China.
Yang BY; Hu LW; Jalaludin B; Knibbs LD; Markevych I; Heinrich J; Bloom MS; Morawska L; Lin S; Jalava P; Roponen M; Gao M; Chen DH; Zhou Y; Yu HY; Liu RQ; Zeng XW; Zeeshan M; Guo Y; Yu Y; Dong GH
JAMA Netw Open; 2020 Sep; 3(9):e2017507. PubMed ID: 32955574
[TBL] [Abstract][Full Text] [Related]
16. PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease.
Schmidt AF; Carter JL; Pearce LS; Wilkins JT; Overington JP; Hingorani AD; Casas JP
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD011748. PubMed ID: 33078867
[TBL] [Abstract][Full Text] [Related]
17. Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.
Schmucker C; Eisele-Metzger A; Meerpohl JJ; Lehane C; Kuellenberg de Gaudry D; Lohner S; Schwingshackl L
Cochrane Database Syst Rev; 2022 Feb; 2(2):CD013556. PubMed ID: 35199850
[TBL] [Abstract][Full Text] [Related]
18. Omega-6 fats for the primary and secondary prevention of cardiovascular disease.
Hooper L; Al-Khudairy L; Abdelhamid AS; Rees K; Brainard JS; Brown TJ; Ajabnoor SM; O'Brien AT; Winstanley LE; Donaldson DH; Song F; Deane KH
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD011094. PubMed ID: 30488422
[TBL] [Abstract][Full Text] [Related]
19. Associations of lipoprotein subclasses with risk of all-cause and cardiovascular disease mortality in individuals with type 2 diabetes: A prospective cohort study.
Li R; Chen JX; Lu Q; Geng TT; Xia PF; Wang Y; Chen LK; Shan ZL; Pan A; Liu G
Diabetes Obes Metab; 2023 Nov; 25(11):3259-3267. PubMed ID: 37492984
[TBL] [Abstract][Full Text] [Related]
20. Screen-based entertainment time, all-cause mortality, and cardiovascular events: population-based study with ongoing mortality and hospital events follow-up.
Stamatakis E; Hamer M; Dunstan DW
J Am Coll Cardiol; 2011 Jan; 57(3):292-9. PubMed ID: 21232666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]